Skip to main content
SpringerLink
Log in

Principles of Quality of Life Assessment in Cancer Chemotherapy

  • Leading Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Aaronson NK, Bakker W, Stewart AL, van Dam FSAM, van Zandwijk N. Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In Aaronson & Beckman (Eds) The quality of life of cancer patients, Raven Press, New York, 1987

    Google Scholar 

  • Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Research 111: 231–249, 1988

    Article  CAS  Google Scholar 

  • Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Medical Care 19: 787–805, 1981

    Article  PubMed  CAS  Google Scholar 

  • Brook RH, Ware JE, Davies-Avery A, Stewart AL, Donald CA, et al. Overview of adult health status measures fielded in Rand’s health insurance study. Medical Care 17 (Suppl. 7): iii–x, 1-131, 1979

    PubMed  CAS  Google Scholar 

  • Campbell A, Converse PE, Rodgers WL. The quality of American life, Russell Sage Foundation, New York, 1976

    Google Scholar 

  • Cassileth BR. The evolution of oncology. Perspectives in Oncology and Medicine 26: 362–374, 1983

    CAS  Google Scholar 

  • Cassileth BR, Lusk EJ, Guerry D, Blake AD, Walsh WP, et al. Survival and quality of life among patients on unproven versus conventional cancer therapy. New England Journal of Medicine 324: 1180–1185, 1991

    Article  PubMed  CAS  Google Scholar 

  • Cassileth BR, Lusk EJ, Strouse TB, Miller DS, Brown LL et al. Psychosocial status in chronic illness: a comparative analysis of six diagnostic groups. New England Journal of Medicine 311: 506–511, 1984

    Article  PubMed  CAS  Google Scholar 

  • Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Annals of Internal Medicine 92: 832–836, 1980

    PubMed  CAS  Google Scholar 

  • Cella DF, Tulsky DS. Measuring quality of life today: methodologic aspects. Oncology 4: 29–38, 1990

    PubMed  CAS  Google Scholar 

  • Donovan K, Sanson-Fisher RW, Redman S. Measuring quality of life in cancer patients. Journal of Clinical Oncology 7: 959–968, 1989

    PubMed  CAS  Google Scholar 

  • Feeny D, Labelle R, Torrance GW. Integrating economic evaluations and quality of life assessments. In Spilker B (Ed.) Quality of life assessments in clinical trials, Raven Press, New York, 1990

    Google Scholar 

  • Finkelstein DM, Cassileth BR, Bonomi PD, Ruckdeschel JC, Ezdinli EZ et al. A pilot study of the functional living index: cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. American Journal of Clinical Oncology 11: 630–636, 1988

    Article  PubMed  CAS  Google Scholar 

  • Freidson E. Professional dominance, Aldine Publishing Company, Chicago, 1970

    Google Scholar 

  • Ganz PA, Moinpour CM, Cella DF, Fetting JH. Quality of life assessment in cancer clinical trials: a status report. Journal of the National Cancer Institute 84: 994–995, 1992

    Article  PubMed  CAS  Google Scholar 

  • Guyatt GH, Jaeschke R. Measurements in clinical trials: choosing the appropriate approach. In Spilker B (Ed.) Quality of life assessments in clinical trials, Raven Press, New York, 1990

    Google Scholar 

  • Jaeschke R, Guyatt GH, Cook D. Quality of life instruments in the evaluation of new drugs. PharmacoEconomics 1: 84–93, 1992

    Article  PubMed  CAS  Google Scholar 

  • Karnofsky DA, Burchenall JH. Clinical evaluation of chemotherapeutic agents. In MacLeod CM (Ed.) Evaluation of chemotherapeutic agents in cancer, Columbia University Press, New York, 1949

    Google Scholar 

  • Moinpour C. Assessment of quality of life in clinical trials. In National Cancer Institute. Quality of life assessment in cancer clinical trials, U.S. Department of Health and Human Services, Bethesda, 1990

    Google Scholar 

  • Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Medical Care 27 (Suppl.): S217–S232, 1989

    Article  PubMed  CAS  Google Scholar 

  • Plosker GL, Milne RJ. Ondansetron. A pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy. PharmacoEconomics 2: 285–304, 1992

    Article  PubMed  CAS  Google Scholar 

  • Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the functional living index — cancer. Journal of Clinical Oncology 2: 472–483, 1984

    PubMed  CAS  Google Scholar 

  • Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In Spilker B (Ed.) Quality of life assessments in clinical trials, Raven Press, New York, 1990

    Google Scholar 

  • Selby P. Measurement of the quality of life after cancer treatment. British Journal of Hospital Medicine 33: 266–271, 1985

    PubMed  CAS  Google Scholar 

  • Slevin ML, Plant H, Lynch D, Frinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? British Journal of Cancer 57: 109–112, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ware JE. Standards for validating health measures: definitions and content. Journal of Chronic Diseases 40: 473–480, 1987

    Article  PubMed  Google Scholar 

  • Wartman SA, Morlock LL, Malitz FE, Palm E. Impact of divergent evaluations by physicians and patients of patients’ complaints. Public Health Reports 98: 141–145, 1983

    PubMed  CAS  Google Scholar 

  • World Health Organization. The constitution of the World Health Organization. WHO Chronicle 1: 29, 1947

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Behavioral Resources Corporation, 8033 Old NC 86, Chapel Hill, North Carolina, 27516, USA

    Barrie R. Cassileth (President)

Authors
  1. Barrie R. Cassileth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cassileth, B.R. Principles of Quality of Life Assessment in Cancer Chemotherapy. PharmacoEconomics 2, 279–284 (1992). https://doi.org/10.2165/00019053-199202040-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199202040-00004

Keywords

Search

Navigation